⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

NVAX

Novavax, Inc.

Healthcare · Biotechnology

9.70USD

-0.2900 (-2.90%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on NVAX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 9.70
P/E—
Dvd Ind Yld0.0%
P/B—
P/S3.9
Curr EV/T12M EBITDA-11.6
Mkt Cap (USD)1.6B
Curr EV (USD)1.2B
2)

Per Share Data

EPS T12M-1.53
DPS—
Bk Val Per Sh-1.16
Rev/Sh2.51
Cash/Sh4.36
Curr Shares Out164.9M
FCF/Sh-4.39
3)

Cash Flow Analysis

P/CF-43.4
Curr P/FCF-2.2
CF/NI0.1
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-8.9%
Eff Interest Rate15.0%
4)

Growth Potential

Dil EPS 1Y Gr309.8%
Cap 1Y Gr118.7%
BPS 1Y Gr82.0%
R&D To Sales82.2%
Retention Rate100.0%
Rev 1Y Gr64.7%
FCF 1Y Gr373.2%
Assets 1Y Gr-24.6%
5)

Profitability

EBITDA-0.2B
EBIT-0.2B
Operating Margin-56.6%
Pretax Margin-59.3%
Net Margin-59.9%
ROA-21.6%
ROE323.7%
ROC—
Asset Turnover0.36
6)

Structure

Current Ratio2.33
Quick Ratio2.23
Debt/Assets30.5%
Debt/Com Eq-153.1%
Net Debt/EBITDA-0.47
Tot Debt/Capital288.5%
Gross Margin78.6%
EBIT/Int Exp-10.7

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.